Exhibit 32.2


              CERTIFICATION OF CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In  connection  with  the  IGENE  Biotechnology,  Inc.  (the
"Company")  Quarterly Report on Form 10-Q for  the  period  ended
September  30,  2008  as filed with the Securities  and  Exchange
Commission  (the  "Report"),  I,  Edward  J.  Weisberger,   Chief
Financial  Officer of the Company, certify pursuant to 18  U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that, to the best of my knowledge:

          (1). The Report fully complies with the requirements of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934, as amended; and

          (2).  The  information contained in the  Report  fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date: November 3, 2008            By: /S/ EDWARD J. WEISBERGER
                                      ___________________________
                                          EDWARD J. WEISBERGER
                                          Chief Financial Officer


A  signed original of this written statement required by  Section
906  has been provided to the Company and will be retained by the
Company  and furnished to the Securities and Exchange  Commission
or its staff upon request.